drugset / Trial / NCT00132444
Study of UC-781 Vaginal Microbicide
Phase 1
Completed
90 enrolled
CONRAD
Centers for Disease Control and Prevention · collabEmory University · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This study will help determine whether the agent UC-781, formulated as a gel, is safe when applied to the vagina twice daily for 14 days. It will also assess whether women find the gel acceptable to use.
Timeline
- Start
- 2005-10
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | UC-781 | Small molecule | 0.1 % | Other |
| Comparator | UC-781 | Small molecule | 0.25 % | Other |